glp 1 npo guidelines A very important and practice-changing consensus statement from the British Journal of Anaesthesia on perioperative management of patients taking GLP-1 receptor agonists such as semaglutide, tirzepatide, and liraglutide. The key message is Outpatient Sedation Basics for Patients

While conclusive human studies are limited, excessive or prolonged use of IGF-1 or IGF1-LR3 should be avoided to minimize potential oncogenic effects

Cautions and warnings: Cautions and warnings: Consult a health-care practitioner prior to use if you are pregnant or breast-feeding

GLP-1 receptor agonists (GLP-1 RAs) are primarily used to treat obesity and type 2 diabetes

Melanotan 1 is more selective, mainly targeting pigmentation pathways, while melanotan 2 (melanotan-ii) interacts with multiple receptors, making it broader in research applications beyond pigmentation.

Following the readout of REDEFINE 1 in late 2024 which fell short of expectations, positive REDEFINE 4 data will become even more important for CagriSema, however, its outcome is now less certain